Hepatitis C Virus Sensitizes Host Cells to TRAIL-Induced Apoptosis by Up-Regulating DR4 and DR5 via a MEK1-Dependent Pathway

Background Hepatitis C virus (HCV) is the leading cause of liver fibrosis, cirrhosis and hepatocellular carcinoma. It is believed that continuous liver cell apoptosis contributes to HCV pathogenesis. Recent studies have shown that HCV infection can sensitize host cells to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis, but the mechanism by which HCV regulates the TRAIL pathway remains unclear. Methods and Results Using a sub-genomic replicon and full length virus, JFH-1, we demonstrate that HCV can sensitize host cells to TRAIL-induced apoptosis by up-regulating two TRAIL receptors, death receptor 4 (DR4) and death receptor 5 (DR5). Furthermore, the HCV replicon enhanced transcription of DR5 via Sp1, and the HCV-mediated up-regulation of DR4 and DR5 required MEK1 activity. HCV infection also stimulated the activity of MEK1, and the inhibition of MEK1 activity or the knockdown of MEK1 increased the replication of HCV. Conclusions Our studies demonstrate that HCV replication sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1 dependent pathway. These findings may help to further understand the pathogenesis of HCV infection and provide a therapeutic target.

[1]  S. Gretton,et al.  Hepatitis C virus RNA replication is regulated by Ras-Erk signalling. , 2010, The Journal of general virology.

[2]  Y. Liu,et al.  Up-Regulation of Hepatitis C Virus Replication and Production by Inhibition of MEK/ERK Signaling , 2009, PloS one.

[3]  M. Yano,et al.  Oxidative stress induces anti‐hepatitis C virus status via the activation of extracellular signal‐regulated kinase , 2009, Hepatology.

[4]  J. Hung,et al.  Heat shock protein 90 is important for Sp1 stability during mitosis. , 2009, Journal of molecular biology.

[5]  Levon M. Khachigian,et al.  Sp1 Phosphorylation and Its Regulation of Gene Transcription , 2009, Molecular and Cellular Biology.

[6]  G. Bren,et al.  HIV Induces TRAIL Sensitivity in Hepatocytes , 2009, PloS one.

[7]  E. Hildt,et al.  Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner1 , 2008, The Journal of Immunology.

[8]  Mark J. Smyth,et al.  The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.

[9]  Xiaohong Liu,et al.  Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells. , 2008, Biochemical and biophysical research communications.

[10]  S. Kitazawa,et al.  Hepatitis C Virus Infection Induces Apoptosis through a Bax-Triggered, Mitochondrion-Mediated, Caspase 3-Dependent Pathway , 2008, Journal of Virology.

[11]  Guo-Dong Lu,et al.  Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation , 2008, Molecular Cancer Therapeutics.

[12]  S. Gibson,et al.  Death receptor-4 (DR4) expression is regulated by transcription factor NF-κB in response to etoposide treatment , 2008, Apoptosis.

[13]  J. Hung,et al.  Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. , 2007, Molecular biology of the cell.

[14]  J. Crawford,et al.  Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. , 2007, Gastroenterology.

[15]  M. Manns,et al.  Increased hepatotoxicity of tumor necrosis factor–related apoptosis‐inducing ligand in diseased human liver , 2007, Hepatology.

[16]  M. Binder,et al.  Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy , 2007, Hepatology.

[17]  H. Blum,et al.  Hepatitis C virus infection and apoptosis. , 2007, World journal of gastroenterology.

[18]  Michael Schwarz,et al.  Regulation of P53 stability in p53 mutated human and mouse hepatoma cells , 2007, International journal of cancer.

[19]  Lifen Gao,et al.  Hepatitis B Virus Sensitizes Hepatocytes to TRAIL-Induced Apoptosis through Bax1 , 2007, The Journal of Immunology.

[20]  Seng-Lai Tan,et al.  Mechanistic link between the anti‐HCV effect of interferon gamma and control of viral replication by a ras‐MAPK signaling cascade , 2006, Hepatology.

[21]  K. Shiraki,et al.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. , 2005, Human pathology.

[22]  K. Shimotohno,et al.  Enhancement of internal ribosome entry site-mediated translation and replication of hepatitis C virus by PD98059. , 2005, Virology.

[23]  J. Hoofnagle,et al.  Mechanism of action of interferon and ribavirin in treatment of hepatitis C , 2005, Nature.

[24]  Charles M. Rice,et al.  Unravelling hepatitis C virus replication from genome to function , 2005, Nature.

[25]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[26]  Mark Harris,et al.  Perturbation of epidermal growth factor receptor complex formation and Ras signalling in cells harbouring the hepatitis C virus subgenomic replicon. , 2005, The Journal of general virology.

[27]  P. Hsu,et al.  Hepatitis C Virus Core Protein Modulates TRAIL-Mediated Apoptosis by Enhancing Bid Cleavage and Activation of Mitochondria Apoptosis Signaling Pathway1 , 2005, The Journal of Immunology.

[28]  G. Gores,et al.  Apoptosis: The nexus of liver injury and fibrosis , 2004, Hepatology.

[29]  G. Gores,et al.  Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. , 2003, Journal of hepatology.

[30]  J. Cohen,et al.  Respiratory Syncytial Virus Infection Sensitizes Cells to Apoptosis Mediated by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand , 2003, Journal of Virology.

[31]  K. Saksela,et al.  The Hepatitis C Virus Non-structural NS5A Protein Inhibits Activating Protein–1 Function by Perturbing Ras-ERK Pathway Signaling* , 2003, The Journal of Biological Chemistry.

[32]  M. Kasuga,et al.  Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma. , 2003, International journal of molecular medicine.

[33]  C. Trautwein,et al.  Involvement of TRAIL and its receptors in viral hepatitis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Charles M. Rice,et al.  Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication , 2002, Journal of Virology.

[35]  A. Bild,et al.  MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage , 2002, Oncogene.

[36]  J. Pouysségur,et al.  Identification of Two Sp1 Phosphorylation Sites for p42/p44 Mitogen-activated Protein Kinases , 2002, The Journal of Biological Chemistry.

[37]  R. Lotan,et al.  Evidence that the human death receptor 4 is regulated by activator protein 1 , 2002, Oncogene.

[38]  Tatsushi Yoshida,et al.  Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL‐R2 gene1 , 2001, FEBS letters.

[39]  J. Silver,et al.  Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .

[40]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[41]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[42]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[43]  L. Zon,et al.  Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1 , 1994, Nature.

[44]  A. Ashworth,et al.  Identification of the sites in MAP kinase kinase‐1 phosphorylated by p74raf‐1. , 1994, The EMBO journal.

[45]  D. Largaespada,et al.  MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[46]  R. Tjian,et al.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. , 1986, Science.

[47]  V. Cicinnati,et al.  Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. , 2008, Journal of hepatology.

[48]  A. Ashkenazi,et al.  Apo2L/TRAIL and its death and decoy receptors , 2003, Cell Death and Differentiation.

[49]  K. Schulze-Osthoff,et al.  Apoptosis in hepatitis C virus infection , 2003, Cell Death and Differentiation.